Berberine, an herbal remedy for diarrhea and intestinal parasites, may be useful in colon cancer therapy.
“Orphan” enzyme may play role in cancer growth, new research suggests.
Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer.
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.
Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis.
A protein critical in heart development may also play a part in colon cancer progression.